Skip to content Skip to footer

International Cannabis Weekly: 263

September 2, 2022

Highlights

Share this story

LAST CHANCE TO SECURE YOUR EARLY BIRD TICKETS FOR BUSINESS OF CANNABIS: NEW YORK!

Produced in partnership with Prohibition Partners, Business of Cannabis: New York will bring together 400+ leaders focused on creating the most successful cannabis market in the US — and one of the biggest in the world. Join 400+ of the North American cannabis industry’s most influential stakeholders as we return to the Big Apple on 3 November.

Due to a global technical issue with the Eventbrite website, we’re aware that some of you weren’t able to purchase tickets for Business of Cannabis: New York at the reduced rate. We have therefore extended Early Bird Ticket sales until midnight EDT tonight (Friday 2 September). Save $100 per ticket before prices rise!

BOOK TICKETS NOW »

LEGAL MEDICAL CANNABIS PRESCRIPTIONS TO BE AVAILABLE IN SPAIN BY 2023

READ MORE »

WHITE HOUSE ISSUES STATEMENT ON SLOW FEDERAL LEGISLATION PROGRESS

READ MORE »

Highlights

Share this story
Europe

Highlights

Share this story
Stocks

Highlights

Share this story
United States

Highlights

Share this story
Canada
  • Aurora Cannabis invests C$45 million to acquire controlling interest of agriculture grower Bevo Farms.
  • Closing of the first tranche of Canada House’s previously announced acquisition of MTL Cannabis.
  • TYSON 2.0, Mike Tyson’s new cannabis brand, will be manufactured by HEXO, in Canada.
  • Entourage Health adds four new union groups to its Starseed cannabis programme.
  • Pre-rolls account for almost 25% of Canada’s 2022 cannabis sales, making them more popular than in the US.
  • First-ever line of vegan gummies has been launched by Glass House, under its value cannabis brand Allswell.
  • Emerald Health Therapeutics Inc. (EMH) has reported its financial information for the last quarter.
  • Pilot project for cannabis micro producers to be launched in Quebec, to facilitate the marketing of new products.

Highlights

Share this story
Upcoming Event

VENUE & AGENDA ANNOUNCED FOR BUSINESS OF CANNABIS: NEW YORK

The wait is nearly over – the venue for Business of Cannabis: New York (previously hosted in the Rainbow Room at the Rockefeller Centre) is set to be announced next week as we bring together the leading figures in the North American cannabis market.

You can expect another iconic venue for this year’s event on 3 November. Keep your eyes peeled for next week’s announcement and find out where all of the action will unfold.

FIND OUT MORE »

Highlights

Share this story
LATAM & The Caribbean
  • Market for the veterinary use of medical cannabis in Brazil could generate around US$288 million.
  • Argentina’s National Survey overthrows the myth that cannabis is the gateway to ‘hard’ drugs.
  • Senasa has participated in the II International Congress of Cannabis & Industrial Hemp in Argentina.
  • The Brazilian cannabis market prepares for regulation, as the country’s cannabis startups begin to boom.

Highlights

Share this story
APAC
  • The New Zealand Medicinal Cannabis Council is looking to make CBD available over the counter.
  • Cronos Australia announces it will pay its first dividend to shareholders, reporting record growth in 2022.
  • Vietnam’s cannabis laws are tough on paper, but penalties are often not as harsh as for other illegal drugs.
  • Bod Australia plans to acquire UK company Aqua Phase, despite reporting a decline in revenue.
  • The third Cannabis as Medicine Survey has been published by researchers from University of Sydney’s Lambert Initiative.
  • The Lambert Initiative reports positive results from a study of the effect of cannabinoids on cancer.

Highlights

Share this story
Africa & The Middle East
Latest Issues

266

265

264

263

262

261

Insights

On the global cannabis industry

International Cannabis Weekly newsletter brings you the most important developments, news and informed commentary on the global cannabis industry. Join our community of 80,000+ subscribers.